Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Chugai, Roche, Genentech File Patent Suit against Fresenius Kabi over Alecensa
March 24, 2020
- KM Biologics, Takeda to Wind Up Sales Partnership on Flu Vaccine
March 24, 2020
- Mochida, Gene Techno Science Pair Up for Regenerative Medicines for Rare Gastrointestinal Diseases
March 24, 2020
- Takeda’s Entyvio Approved in China
March 24, 2020
- Kitasato Institute Embarks on Drug Screening Project for COVID-19
March 23, 2020
- Oncolys to Create US Non-Clinical Research Subsidiary, Accelerating Drug R&D
March 23, 2020
- Eiken’s Novel Coronavirus Detection Reagent Kit Bags Public Insurance Coverage
March 23, 2020
- Asahi Kasei Grabs Global Rights for SBI Biotech’s Autoimmune Disease Therapy
March 23, 2020
- Fujifilm to Scale Up Production Capacity at UK Subsidiary with 9 Billion Yen Investment
March 23, 2020
- (Update) Japan Approves Novartis’ SMA Gene Therapy Zolgensma; 15-20 Patients Expected Annually
March 19, 2020
- Nipro Confirms Second Coronavirus Case, Again in Niigata
March 19, 2020
- RIMD, BIKEN, NIBIOHN Start Development of COVID-19 Vaccine/Test Technology
March 19, 2020
- Eiken Launches Novel Coronavirus Detection Reagent Kit
March 19, 2020
- Post-Promotion Guidelines - 1: Drug Makers Struggling to Establish Non-Sales Criteria for Rep Performance Review
March 18, 2020
- Kyorin to Develop High-Speed PCR System for Coronavirus Detection, Eyes Launch by March-End
March 18, 2020
- Chugai Recalls Herceptin over Glass Contamination
March 18, 2020
- Shionogi Seeks Collaboration with Lab Test Service Provider on Coronavirus Antibody-Test Kit in Japan
March 18, 2020
- Pfizer Joining Fray in Japan AG Market with Celecox
March 17, 2020
- Fujifilm Plans Company-Sponsored Avigan Trial for COVID-19 in Japan
March 17, 2020
- Shigeo Taniuchi to Become CEO of Santen
March 16, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…